Stock comparison
AbbVie
ABBV$465.26BHealthcare Market cap, Sector
Pfizer
PFE$163.69BHealthcare Market cap, Sector
AbbVie
ABBV 52 PFE
Based on the combined fit scores from all four strategies. The breakdown by strategy is below.
Fit scores by strategy
Side-by-side metrics
| Metric | ABBV | PFE |
|---|---|---|
| Market cap | Winner: $465.26B | $163.69B |
| P/E (TTM) | 102.5x | 18.9x Winner |
| EV/EBIT | 52.2x | 20.6x Winner |
| ROIC (TTM) |
Where each one wins
The metrics with the widest gap between the two, biggest differences first.
ABBV leads on
- Revenue CAGR 5y1.75%vs -14.8%+112%
- Debt / Equity-vs 0.7x+104%
- Market cap$465.26Bvs $163.69B+65%
- ROIC (TTM)11.97%vs 5.49%+54%
PFE leads on
More like ABBV
More like PFE
Related on invest-like
For education only. Fit scores apply each investor's published criteria to public financial data. They are not personal recommendations.